Zheng Quan Ri Bao Zhi Sheng·2025-10-21 11:41Core Insights - Huabang Health, established in 1992, is a leading enterprise in the field of clinical skin medications and skin health in China [1] - The company has developed a diversified business model focusing on the health industry, with independent operations in agricultural chemicals, new materials, and tourism [1] - Huabang Health's business scope includes five major areas: pharmaceuticals, medical services, agricultural chemicals, new materials, and tourism [1] Business Structure - The company controls three listed subsidiaries: Yingtai Biotechnology (920819.BJ), Kaisheng New Materials (301069.SZ), and Lijiang Co. (002033.SZ) [1] - It also holds a controlling stake in a New Third Board enterprise, Qinling Tourism (870256.NQ), and has a stake in another New Third Board company, Purikin (874090.NQ) [1] Future Strategy - The company plans to adhere to its development strategy in pharmaceuticals and medical health, continuously improving its full industry chain model that integrates raw materials, formulations, functional skincare products, comprehensive skin health management, and medical services [1] - Huabang Health aims to maintain the independent and stable operation of its three listed companies while leveraging its role as a controlling shareholder in governance [1]